TNF and neoplasm: Thus, therapeutically shifting the balance from T celllow/M2 macrophagehigh/BL towards T cellhigh/macrophagelow/CLA-like state through inhibition of TNF-α with GEM chemotherapy may provide a valuable strategy to enhance anti-tumor immunity and treatment response in PDAC.